AETHOXYSKLEROL

This brand name is authorized in Austria, Finland, Japan, Lithuania, Malta, Netherlands, Poland, Turkey, UK.

Active ingredients

The drug AETHOXYSKLEROL contains one active pharmaceutical ingredient (API):

1
UNII 0AWH8BFG9A - POLIDOCANOL
 

Polidocanol has a concentration-dependent and volume-dependent damaging effect on the endothelium of blood vessels.

 
Read more about Polidocanol

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 AETHOXYSKLEROL Solution for injection MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
C05BB02 Polidocanol C Cardiovascular system → C05 Vasoprotectives → C05B Antivaricose therapy → C05BB Sclerosing agents for local injection
Discover more medicines within C05BB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
FI Lääkealan turvallisuus- ja kehittämiskeskus 405647, 462069, 462093
GB Medicines & Healthcare Products Regulatory Agency 115018, 115022, 115026, 115030, 115034
JP 医薬品医療機器総合機構 3329405A1022
LT Valstybinė vaistų kontrolės tarnyba 1091315, 1091317, 1091318, 1091319
MT Medicines Authority AA565/36201, AA729/28101
NL Z-Index G-Standaard 14274655, 14274663, 14274671, 14274701
NL Z-Index G-Standaard, PRK 2143, 3719, 3727, 3735
PL Rejestru Produktów Leczniczych 100107315, 100107321, 100107338, 100169380, 100192723
TR İlaç ve Tıbbi Cihaz Kurumu 8699699771050, 8699708751745, 8699708751752, 8699708751769, 8699708751776, 8699708751783

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.